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In patients with falciparum malaria, plasma concentrations of cell-derived microparticles correlate with
disease severity. Using flow cytometry, we quantified red blood cell–derived microparticles (RMPs) in patients
with malaria and identified the source and the factors associated with production. RMP concentrations were
increased in patients with Plasmodium falciparum (n5 29; median, 457 RMPs/lL [range, 13–4,342 RMPs/lL]),
Plasmodium vivax (n 5 5; median, 409 RMPs/lL [range, 281–503/lL]), and Plasmodium malariae (n 5 2;
median, 163 RMPs/lL [range, 127–200 RMPs/lL]) compared with those in healthy subjects (n 5 11; median,
8 RMPs/lL [range, 3–166 RMPs/lL]; P 5 .01). RMP concentrations were highest in patients with severe
falciparummalaria (P5 .01). Parasitized red cells produced.10 times more RMPs than did unparasitized cells,
but the overall majority of RMPs still derived from uninfected red blood cells (URBCs). In cultures, RMP
production increased as the parasites matured. Hemin and parasite products induced RMP production in
URBCs, which was inhibited by N-acetylcysteine, suggesting heme-mediated oxidative stress as a pathway for
the generation of RMPs.
In recent years, circulating cell-derived microparticles
(MPs), which expose the phospholipid phosphatidyl
serine (PS), have been identified increasingly in a broad
range of diseases. Membrane PS is usually localized in
the inner leaflet of the lipid bilayer of resting cells, but
upon activation or apoptosis, PS becomes exposed on
the external surface of the cell membrane [1, 2]. The
presence of PS in the outer leaflet facilitates membrane
blebbing and release of MPs with a diameter of ,1 lm
[3]. MPs display the cell surface proteins of the parent
cell, allowing identification of their origin [4]. An in-
crease in MP production has been found in a variety of
conditions, including cardiovascular disease [5], idio-
pathic thrombocytopenic purpura [6], and thalassemia
[7, 8]. MPs play an important role in inflammation,
coagulation, and vascular homeostasis [4, 9]. Malaria is
associated with an increase in the plasma concentrations
of endothelial MPs (EMPs) in proportion to disease
severity [10, 11]. This may result from endothelial ac-
tivation or be a direct mechanical result of cytoadher-
ence of parasitized red cells to the endothelium. The
origin and role of red blood cell–derived MPs (RMPs) in
malaria, which comprise numerically the most impor-
tant fraction of plasma MPs, have not been established.
We quantified circulating RMPs in patients with malaria
on admission and then after antimalarial treatment by
use of flow cytometry and determined whether un-
infected red blood cells (URBCs) or infected red blood
cells (IRBCs) were the main origin of these RMPs. We
investigated a candidate precipitant of RMP production,
hemin, an oxidative Plasmodium falciparum heme
product released at schizont rupture. We also evaluated
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the parasite stage-specific production of IRBC-derived RMPs in
an in vitro culture system.
METHODS
Detection of RMPs in Plasma Samples From Patients With
Malaria
Blood Samples. This study was performed at the Hospital
for Tropical Diseases, Bangkok, Thailand. Blood samples were
collected from 11 healthy subjects, 19 patients with severe fal-
ciparum malaria, 10 patients with uncomplicated falciparum
malaria, 5 patients with vivax malaria, and 2 patients with
Plasmodium malariae infections. Malaria diagnosis was made by
light microscopic analysis of a peripheral blood sample slide.
Severe malaria was defined according to standard criteria [12].
Patients were treated with standard courses of artemisinin de-
rivatives. Blood samples were collected into plastic tubes con-
taining trisodium citrate (1:9 vol/vol) on admission and on days
1, 2, 3, 5, 7, and 14 after the start of antimalarial drug treatment.
Plasma for RMP assessment was centrifuged at 1,500 g for
15 min followed by additional centrifugation of the supernatant
at 13,000 g for 2 min [11]. Routine blood samples collected from
patients hospitalized with trauma (n 5 5) and sepsis (n 5 6)
were assessed as nonmalaria severely ill controls. This study was
conducted as part of a clinical trial conducted at the Faculty of
Tropical Medicine, Mahidol University, and approved by the
ethics committee of the Faculty of Tropical Medicine, Mahidol
University, Bangkok, Thailand.
Quantitation of MPs Using Flow Cytometry. A specific
marker for phospholipid PS (fluorescein isothiocyanate [FITC]–
conjugated annexin V) and phycoerythrin (PE) –conjugated
anti-glycophorin A were used for identification of RMPs.
Plasma (30 lL) was mixed with 2 lL of FITC-conjugated
annexin V (Becton Dickinson Biosciences) and 2 lL of PE-
conjugated anti-glycophorin A (Becton Dickinson Biosciences).
These mixtures were incubated with 16 lL of binding buffer at
room temperature and protected from light for 15 min, after
which they were diluted with 1000 lL of binding buffer and
quantified by flow cytometry (FACsCalibur; Becton Dickinson
Biosciences) within 1 h by use of a modification of a flow-rate-
based assay reported elsewhere [13–15]. RMPs were localized
within region R1 and were distinguished from debris by annexin
V– and glycophorin A–associated responses in the upper right
quadrant (Figures 1A and 1B). The absolute number of RMPs
was calculated using the following formula:
where # 5 (number of prebead RMPs 1 number of postbead
RMPs)/2 and K5 (dilution factor 3 calibration factor)/diluent
volume 5 2.9 3 1025 [15].
RMP Production in an In Vitro Culture of P. falciparum
Parasite Culture. The Thai laboratory strain of P. falcipa-
rum (TM267) was cultured in vitro at 3% hematocrit in Roswell
Park Memorial Institute 1640 medium (RPMI1640; ICN Bio-
medical) containing 10% human AB serum in a 5% carbon
dioxide environment at 37C, as described elsewhere [16]. To
ensure synchronous parasite cultures, the samples were treated
with 5% sorbitol [17]. Culture supernatant was sampled every 6
h for detection of RMPs, and slides for microscopy were pre-
pared at each time point to assess parasitemia and parasite de-
velopment. Morphological criteria for the light microscopic
assessment of developmental stages of P. falciparum have been
described elsewhere [18].
Assessment of Parasitized Versus Nonparasitized Red Blood
Cells as the Source of RMPs. In contrast to unparasitized
red blood cells (RBCs), parasitized RBCs contain membrane-
associated ring-infected erythrocyte surface antigen (RESA) and
possibly other parasite-derived antigens, which can be identified
by immunofluorescence by use of plasma obtained from im-
mune P. falciparum–infected patients. Thus, MPs derived from
parasitized red cells, and also from cells that have been once
parasitized and then pitted, are RESA positive, and MPs derived
from erythrocytes that have never been parasitized are RESA
negative. RMPs in 5 mL of culture medium were prepared as
described above by 2-step centrifugation [10, 11]. Annexin V-PE
(Becton Dickinson Biosciences; catalogue no. 5165875X) and
Cy5-conjugated anti-glycophorin A (Becton Dickinson Bio-
sciences; catalogue no. 559944) was used to quantify the com-
bined fractions of RMPs as described above. Samples were fixed
with 100 lL of .05% glutaraldehyde for 30 min and then in-
cubated with 100 lL of plasma containing anti-RESA-positive
antibody for 30 min. Five microliters of cell suspension was then
labeled with 5 lL of FITC-conjugated human immunoglobulin
G (IgG; Dako; catalogue no. F0202), 5 lL of PE-conjugated
annexin V, and 5 lL of Cy5-conjugated anti-glycophorin A. This
mixture was subsequently incubated for 30 min at room tem-
perature and protected from light. After incubation, 1 mL of
diluted binding buffer solution (1:10 vol/vol in distilled water)
was added and the sample was analyzed by flow cytometry using
flow-rate-based calibration [15]. The origin of the RMPs was
identified by analysis of the forward scatter and side scatter
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patterns, which denote the RESA-positive IRBC-derived RMPs
as a fraction of the total number of RMPs (Figure 1C). The
fraction of RESA-positive RMPs was calculated using CellQuest
software version 3.3 (Becton Dickinson Biosciences). The con-
tribution of circulating parasitized erythrocytes to the total RMP
concentration was derived as follows: ratio of RMPs produced
by parasitized cells to RMPs produced by unparasitized cells 5
(RESA-positive RMPs/RESA-negative RMPs) 3 (100 2
parasitemia/parasitemia), where parasitemia is a percentage.
This estimate assumes RMPs are derived from the circulating
parasitized and unparasitized erythrocytes, and that there is
no significant contribution from previous generations of
parasitized cells.
Effects of Hemin on RMP Production
A stock hemin solution was freshly prepared at the beginning of
each experiment by dissolving .1 g of hemin chloride (Sigma) in
1 mL of .1 mol/L sodium hydroxide and 9 mL of phosphate-
buffered saline. The hemin solution was then diluted to 12.5, 25,
50, or 100 lg/mL with RPMI 1640 and used immediately. Blood
samples were obtained from healthy human volunteers by ve-
nipuncture into heparinized tubes and centrifuged at 1,100 g
for 10 min at 4C. Plasma was removed and packed RBCs were
washed with RPMI 1640. After removal of the buffy coat, washed
RBCs were resuspended in hemin in concentrations ranging
from 12.5 to 100 lg/mL with a final hematocrit of 5% in the
presence or absence of 1 mg/mL N-acetylcysteine (Parvolex
injection; 200 mg/mL). RMPs were separated from RBC rem-
nants by centrifugation at 1,500 g for 15 min, and then the
supernatant was further centrifuged at 13,000 g for 2 min.
RMPs were quantitated by flow cytometry using the specific
RBC monoclonal antibody (PE-CD235; Beckman Coulter Im-
munotech) doubled with FITC-conjugated annexin V. Results
are expressed as the median (range) number of RMPs per
microliter.
Statistical Analysis
Statistical analyses were performed using the SPSS statistical
program (version 11.0; SPSS). Non-normally distributed pa-
rameters were compared using the Kruskal-Wallis and Mann-
Whitney U tests. Correlations were assessed by the method of
Spearman for non-normally distributed variables. A P value of
,.05 was considered to be statistically significant.
RESULTS
Quantification of RMPs in Patients with Malaria
A total of 36 patients with acute P. falciparum, Plasmodium
vivax, or P. malariae infection were studied. Baseline clinical
and laboratory characteristics are summarized in Table 1.
Patients with severe malaria had higher peripheral blood
parasitemia (P 5 .01), higher serum aspartate amino-
transferase (AST) levels (P 5 .01), and lower plasma glucose
levels (P 5 .01) compared with those of patients with
uncomplicated malaria (Table 2).
On admission, concentrations of RMPs were increased in all
malaria patients, with a median concentration in P. falciparum
malaria (n 5 29) of 457 RMPs/lL (range, 13–4,342 RMPs/lL),
in P. vivax malaria (n 5 5) of 409 RMPs/lL (range, 281–503
RMPs/lL), and in P. malariae malaria (n 5 2) of 163 RMPs/lL
(range, 127–200 RMPs/lL) compared with 8 RMPs/lL (range,
3–166 RMPs/lL) in healthy controls (n 5 11; P , .001)
(Table 3). The median RMP concentration in patients with
Figure 1. Flow cytometric quantitation of plasma red blood cell–
derived microparticles (RMPs) in blood samples from patients with
malaria. A, RMPs gated by size on a forward scatter and side scatter plot.
B, Only events included within gate M3 were further analyzed for
fluorescence associated with annexin V– and glycophorin A–positive
labeling. C, Analysis of the origin of RMPs with positive staining by anti–
ring-infected erythrocyte surface antigen (RESA) antibodies denoting
a parasitized red cell origin. RMPs were identified as either RESA positive
(M2) or RESA negative (M1).
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trauma was 208 RMPs/lL (range, 85–463 RMPs/lL; n5 6), and
that in patients with sepsis was 175 RMPs/lL (range, 125–205
RMPs/lL; n 5 6).
RMP concentrations in patients with severe falciparum ma-
laria (n 5 19) were higher than in patients with uncomplicated
falciparum malaria (n510), with a median concentration of 535
RMPs/lL (range, 13–4,342 RMPs/lL) versus 276 RMPs/lL
(range, 15–2,150 RMPs/lL), respectively (P5 .01) (Figure 2). In
patients with falciparum malaria, the concentration of RMPs
was correlated positively with the peripheral blood parasitemia
(rs 5 .73; P 5 .01).
After antimalarial treatment, the level of RMPs decreased
rapidly to ,400 RMPs/lL after 24 h and continued to decrease
further between days 3 and 14. Nevertheless, the median RMP
concentrations still remained above reference levels at 14 d after
the start of antimalarial treatment (median, 96 RMPs/lL [range,
9–921 RMPs/lL] for all groups) (Figure 3). The origin of the
RMPs in the plasma of severe malaria patients (N 5 5) was
investigated. If the contribution of previous generations of
parasitized cells and schizont rupture is ignored, and if RESA-
positive RMPs are assumed to come from the circulating
parasitized erythrocytes, then each parasitized erythrocyte
contributed a median of 13 (range, 4–68) times more MPs than
each unparasitized cell.
Release of RMPs During Parasite Development
RMP concentrations were assessed every 6 h in the supernatant
of a synchronized P. falciparum in-vitro culture (N 5 5) and
analyzed in relation to parasite stage of development. RMP
production in vitro increased as the parasites matured, with
lower-level production in ring-stage-infected RBCs (median
resulting concentration, 200 RMPs/lL [range, 168–220 RMPs/
lL] increasing to 390 RMPs/uL [range, 369-498 RMPs/uL];
P 5 .01 for trend). The fraction of RMPs derived from infected
Table 1. Baseline Characteristics of Enrolled Patients with Plasmodium falciparum, Plasmodium vivax, and Plasmodium malariae
Infection
Characteristic Patients with PF (n 5 28) Patients with PV (n 5 5) Patients with PM (n 5 2)
Parasitemia, parasites/lL 37,077 (400–1,180,690) 10,500 (4,635–28,109) 6,029 (3,818–8,239)
Hematocrit, % 37.7 (14.5–44.7) 37.3 (24.10–41.80) 31.6 (30.4–32.8)
Hb level, g/dL 12.4 (4.8–15.4) 12.8 (7.6–14) 11 (10.5–11.5)
AST level, IU/L 44 (13–184) 35 (25–50) 36 (19–53)
ALT level, IU/L 36 (17–126) 26 (16–37) 35 (32–38)
Serum bilirubin level, mg/dL 1.17 (.11–18.37) .46 (.2–.78) .5 (.21–.79)
Total bilirubin level, mg/dL 2.52 (.63–23.86) 1.26 (.84–2.22) 1.39 (.74–2.04)
BUN level, mmol/L 21 (8–85) 16 (10–138) 12.5 (9–16)
Creatinine level, lmol/L 1.1 (.6–3.98) .99 (.62–.99) .94 (.92–.95)
Glucose level, mmol/L 6.6 (4.3–13.1) 7.1 (5.2–8.7) 6.2 (5.9–6.4)
Plasma lactate level, mmol/L 4.39 (2.45–12.70) NA NA
NOTE. Data are median (range) values. ALT, alanine aminotransferase; AST, aspartate aminotransferase; BUN, blood urea nitrogen; Hb, hemoglobin; NA, not
available; PF, P. falciparum infection; PM, P. malariae infection; PV, P. vivax infection.
Table 2. Baseline Characteristics of Enrolled Patients With Uncomplicated Falciparum Malaria and Severe Falciparum Malaria
Characteristic Patiens with UM (n 5 10) Patients with SM (n 5 18)
Parasitemia, parasites/lL 14,821 (1,160–92,115) 314,654 (139,332–489,975)a
Hematocrit, % 37.8 (28.6–42.8) 34 (30–39)
Hb level, g/dL 12.4 (8.9–14.8) 11.63 (9.98–13.27)
AST level, IU/L 23 (13–46) 75 (51–98)a
ALT level, IU/L 28 (17–41) 52 (36–69)
Serum bilirubin level, mg/dL .35 (.11–.89) 2.47 (.73–18.37)a
Total bilirubin level, mg/dL 1.2 (.63–2.24) 5.95 (1.65–23.86)a
BUN level, mmol/L 17 (8–24) 32 (21–43)a
Creatinine level, lmol/L .86 (.65–1.27) 1.17 (.8–1.55)
Glucose level, mmol/L 6.4 (4.3–13.1) 6.8 (5.9–7.8)
Plasma lactate level, mmol/L 3.78 (3.03–6.18) 6.58 (3.15–12.7)a
NOTE. Data are median (range) values. ALT, alanine aminotransferase; AST, aspartate aminotransferase; BUN, blood urea nitrogen; Hb, hemoglobin; SM, severe
falciparum malaria; UM, uncomplicated falciparum malaria.
a aP , .01 compared with patients with UM.
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red blood cells in vitro, defined as RMPs positively staining with
both annexin V and anti-RESA antibody plus FITC-conjugated
IgG, was overall 39% of the total RMPs. In synchronized culture
(5% parasitemia and 5% hematocrit), the mean proportion of
the total RMPs positively staining with anti-RESA was 39% (SD,
2%) for ring-stage parasites, 31% (SD, 8%) for trophozoite-
stage parasites, and 39% (SD, 5%) for schizont-stage parasites.
After schizont rupture, the mean proportion of RMPs positively
staining with anti-RESA was 47% (SD, 4%). The mean pro-
portion of RMPs released by infected cells compared with that
released by uninfected cells was estimated to be 12 (SD, 1) for
the ring stage, 9 (SD, 3) for the trophozoite state, 12 (SD, 3) for
the schizont stage, and 17 (SD, 1) after schizont rupture.
Release of RMPs After Hemin Treatment
Uninfected red blood cells were incubated with hemin (12.5–100
lg/mL) for 2–6 h in the presence or absence of the antioxidant
N-acetylcysteine in a concentration of 1 mg/mL. RMP pro-
duction increased with increasing hemin concentrations and
was maximal after incubation with 100 lg/mL of hemin expo-
sure in the supernatant for 6 h with a median concentration of
700 RMPs/lL (range, 638882 RMPs/lL). This effect was in-
hibited when the red blood cells were incubated concomitantly
with N-acetylcysteine (1 mg/mL) and hemin (P 5 .01).
DISCUSSION
This study quantifies circulating RMPs during malaria infection.
Plasma RMP concentrations were increased in patients with
falciparum malaria in proportion to disease severity, and were
also increased in patients with P. vivax and P. malariae in-
fections, although to a lesser extent. RMP concentrations were
also higher in patients with severe malaria than in patients with
trauma or severely ill in sepsis. Concentrations of RMPs de-
creased 24 h after initiation of antimalarial drug treatment, al-
though in patients with P. falciparum malaria, the circulating
RMP levels remained increased for 2 weeks after the start of
antimalarial treatment. In contrast, in patients with P. vivax and
P. malariae infections, MPs concentrations were lower and de-
creased to baseline levels within 2 weeks after the start of
treatment. Removal by the spleen is likely to be the most im-
portant contributor to the clearance of RMPs from the circu-
lation, since it has been shown that splenectomized malaria
patients have increased levels and prolonged circulation of MPs
[7]. During malaria infection the spleen enlarges and is acti-
vated, increasing its clearance capacity [19]. Cells and particles
that express PS on their surface are removed by the splenic
reticuloendothelial system. The liver and the lungs can also
contribute to the clearance of RMPs as has been shown in
a murine animal model [20]. The production of RMPs in
Table 3. Total Red Cell–derived Microparticles in Patients With Severe Falciparum Malaria, Nonsevere Falciparum Malaria, Vivax
Malaria, or Malariae Malaria and Healthy Subjects
No. of red cell–derived microparticles, median (range)
Day Patients with SM Patients with UM Patients with PV Patients with PM Healthy subjects
0 535 (13–4,342)a 276 (15–2,150)a 409 (281–503)a 163 (127–200)a 8 (3–166)
1 269 (41–1,979)a 150 (33–360)a 47 (14–266)a,b 122 (114–130) NA
2 159 (16–524)a 96 (33–478)a 162 (24–369)a,b 268 (NA) NA
3 146 (28–963)a,b 84 (13–759)a 52 (38–316)a,b 155 (134–175) NA
5 115 (35–476)a,b 156 (7–1,387)a 121 (11–774)a,b 102 (100–105) NA
7 112 (35–1,830)a,b 38 (9–317)a,b 49 (13–808)a,b 125 (46–205) NA
14 156 (9–921)a,b 45 (10–410)a,b 18 (6–64)b 48 (NA) NA
NOTE. NA, not available; PM, malariae malaria; PV, vivax malaria; SM, severe falciparum malaria; UM, nonsevere falciparum malaria.
a P , .05 compared with healthy subjects.
b P , .01 compared with value on admission day (day 0).
Figure 2. Plasma red blood cell–derived microparticles in blood
samples collected at admission from healthy subjects, patients with
uncomplicated Plasmodium falciparum infection (UM), patients with
severe P. falciparum infection (SM), patients with Plasmodium vivax
infection (PV), and patients with Plasmodium malariae infection (PM).
*P , .001 compared with healthy subjects. Data are represented as the
mean (6 SD).
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a P. falciparum in vitro culture system was increased during the
latter stages of the parasite asexual life cycle. Parasitized cells
produced considerably more RMPs per cell at all stages of de-
velopment than did unparasitized cells both in vivo and in vitro.
It was estimated that parasitized red cells contributed 13 times
more RMPs than do uninfected red cells in severe malaria. This
is consistent with other observed changes in URBCs during se-
vere malaria infections, which include a marked reduction in
their deformability [21]. RMP production by URBCs could be
mediated by the release of malaria heme products at the schizont
rupture, which is also one of the proposed mechanisms for the
reduction in uninfected red cell deformability. We showed that
hemin induces the production of RMPs in a concentration- and
time-dependent manner. This is probably mediated through an
oxidative mechanism, since the antioxidant N-acetylcysteine
almost completely blocked RMP production. Oxidative stress
is increased during malaria infection and is thought to be
generated by both malaria heme products and the host immune
response [22, 23].
It has been shown in previous studies that PS is expressed on
the outer membrane leaflet in IRBCs and that PS expression is
related to parasite maturation [24, 25], which suggests that the
vesiculation process leading to MP formation is related to active
red cell membrane changes induced by the growing parasite.
Studies by Lang and colleagues [26] showed that infection of
RBCs by P. falciparum leads to activation of several distinct
anion channels and a nonselective, Ca21-permeable cation
channel. These channels could be activated by oxidative stress
generated by the parasite. Similar or identical channels are ac-
tivated by oxidation of noninfected erythrocytes [22]. Activation
of the nonselective cation channel allows entry of Ca21 and Na1,
both of which are required for intracellular growth of the par-
asite. Entry of Ca21 is known to stimulate a phospholipid
scramblase, which is a protein responsible for the bidirectional
phospholipid migration across the lipid bilayer, resulting in
breakdown of the PS asymmetry of the cell membrane. The
exposure of PS at the outer surface of the cell membrane could
be followed by binding to PS receptors on macrophages and
subsequent phagocytosis of the affected RBCs [1, 5]. Mainte-
nance of the normal asymmetry by vesiculation may represent
an important parasite strategy to avoid recognition and de-
struction by the host reticuloendothelial system [27, 28]. This
study identifies different sources of plasma RMPs in patients
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Figure 3. Plasma red blood cell–derived microparitcle (RMP) concentrations in malaria patients with severe Plasmodium falciparum infection (A),
uncomplicated P. falciparum infection (B), and Plasmodium vivax infection (C) following antimalarial drug treatment. Data are represented as the
mean (6 SE).
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concentrations with disease severity. Parasite maturation evokes
the release of RMPs from infected erythrocytes, whereas the
quantatively more important production of RMPs from
uninfected erythrocytes might be triggered by an oxidative-
stress-related mechanism through heme exposure.
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